Patents
Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
10/2002
10/31/2002WO2002085403A1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5
10/31/2002WO2002085395A1 Total glycosides of paeony, method to prepare the same and uses thereof
10/31/2002WO2002085359A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases
10/31/2002WO2001052746A9 Versatile hydrophilic dyes
10/31/2002US20020161221 Ether type lipid a 1-carboxylic acid analogs
10/31/2002US20020161206 For inhibiting tumor cell growth
10/31/2002US20020160964 Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same
10/31/2002CA2445508A1 Agent for topical ophthalmic treatment of ocular inflammatory diseases
10/31/2002CA2444907A1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5
10/31/2002CA2444055A1 Bacteriotoxin adsorbents and method of screening the same
10/30/2002EP1252171A1 Method for preparing functionalised beta-(1,3)-glucan derivatives
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP1251859A1 Novel compounds
10/30/2002EP1090017B1 Novel compounds derived from alpha-d-xylose, preparation method and therapeutic use
10/29/2002US6473512 Apparatus and method for a custom soft-solid hearing aid
10/29/2002US6472158 Ustilipides, method for the production and the use thereof
10/29/2002CA2088128C Salts of glucopyranose derivatives and its intermediate
10/29/2002CA2014486C Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyltrithio group
10/24/2002WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002WO2002083066A2 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
10/24/2002WO2000039137A3 Regiospecific synthesis of glucose-based surfactants
10/24/2002US20020156117 Receptor-avid exogenous optical contrast and therapeutic agents
10/24/2002US20020156022 Compounds and methods for treating transplant rejection
10/24/2002US20020155999 Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer
10/24/2002US20020155565 FAP-activated anti-tumor compounds
10/24/2002US20020155094 Method of treating sepsis and ARDS using chemokine beta-9
10/24/2002CA2444481A1 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
10/24/2002CA2444264A1 Prodrugs via acylation with cinnamate
10/23/2002EP1250333A1 Dendrimer precursor dyes for imaging
10/23/2002EP1250141A1 Prevention and treatment of endotoxemia and related complications associated with surgery
10/23/2002EP1250095A1 Versatile hydrophilic dyes
10/23/2002CN1376158A Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them
10/23/2002CN1375499A Method of extracting and separating several components from mangsteen
10/22/2002US6469148 Of high isomeric purity, includes reacting a benzaldehyde, zinc chloride solution with galactose, filtering, diluting filtrate with organic solvent, extracting with cold water and ion exchanging to remove zinc ions
10/22/2002US6468939 Esters of phosphoric acid, phosphorous acid, phosphonic acid, phosphonous acid, phosphinic acid or phosphinous acid; complexing ligands
10/22/2002CA2227264C Amine acid salt compounds and process for the production thereof
10/22/2002CA2040437C Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor
10/17/2002WO2002081491A2 New genistein derivatives and pharmaceutical preparations containing them
10/17/2002WO2002081483A2 Inhibitors of acyl glucosaminyl inositol amidase and methods of use
10/17/2002WO2002081480A1 Compounds and pharmaceutical compositions for inhibiting mrp1
10/17/2002WO2002081466A1 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
10/17/2002WO2002080936A1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
10/17/2002WO2002032860A3 Dynamic organ function monitoring agents
10/17/2002US20020151505 Treatment of helicobacter with isothiocyanates
10/17/2002US20020150936 Biosynthesis of 2'-O-silyl-nucleoside phosphoramidite; obtain nucleoside, incubate with silyl compound, desilylate, incubate with phosphoramidate, recover nucleoside phosphoramidate
10/17/2002CA2442141A1 Compounds and pharmaceutical compositions for inhibiting mrp1
10/16/2002EP1248761A1 Compounds which mimic the chemical and biological properties of discodermolide
10/16/2002EP1248629A1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
10/16/2002EP0948509B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
10/16/2002EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002CN1374969A FAP-activated anti-tumor compounds
10/15/2002US6465625 Taxol derivatives
10/10/2002WO2002079213A1 Process for the preparation of 2'-halo-$g(b)-l-arabinofuranosyl nucleosides
10/10/2002WO2002079150A2 Glycorandomization and the production of novel erythronolide and coumarin analogs
10/10/2002WO2002078597A2 Oral absorbed drugs
10/10/2002WO2002051862A3 Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units
10/10/2002US20020147353 Drugs; oxidaton resistance
10/10/2002US20020146390 Therapy of sepsis and adult respiratory distress syndrome using chemokine or biologically active fragment thereof, alone or in conjunction with an anti-infective agent
10/09/2002EP1246826A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
10/09/2002EP1129208B1 Vancoresmycin, a process for its production and its use as a pharmaceutical
10/08/2002US6462191 Synthesis of 2-deoxy-2-fluoro-arabinose derivatives
10/08/2002US6462183 Protected aminosugars
10/08/2002US6462182 Chemotherapy, microbial infections; enhanced solubility; catalysis, hydrolysis
10/03/2002WO2002077255A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
10/03/2002WO2002077004A1 Synthetic derivatives of 21-butenyl and related spinosyns
10/03/2002WO2002076448A1 Molecular conjugates for use in treatment of cancer
10/03/2002WO2002076402A2 Fatty amine drug conjugates
10/03/2002WO2002030942A3 Anhydro sugar derivatives of indolocarbazoles
10/03/2002US20020141972 Administering protein and antiinflection agent
10/03/2002CA2441484A1 Molecular conjugates for use in treatment of cancer
10/03/2002CA2441412A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
10/02/2002EP1244417A1 Use of alkyl- and/or alkenyloligoglycoside fatty acid esters for improving the sensory evaluation of emulsions
10/02/2002EP0843675B1 Aza-anthracyclinone derivatives
10/02/2002DE10111682A1 Caloporosid-Derivate, Verfahren zu deren Herstellung und deren Verwendung Caloporoside derivatives, processes for their preparation and their use
10/02/2002CN1371690A Vaccine composition for initiating anti-N-glycolyl ganglioside immunoreaction and application thereof
10/02/2002CN1091791C 钻井液 Drilling
10/02/2002CN1091773C Process for preparing yam saponin
10/02/2002CN1091604C Processed ginseng extract having enhanced pharmacological offset and preparation method
10/01/2002US6458937 Glycoconjugates and methods
10/01/2002US6458401 Process for producing a powder containing crystalline particles of maltitol
10/01/2002CA2235943C Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
09/2002
09/26/2002WO2002074737A2 Process for the preparation of 2-hydroxymethyl-pyrolidine-3,4-diols
09/26/2002WO2000064917A3 Synthetic indolocarbazole regioisomers and uses thereof
09/26/2002US20020137903 Sodium dependent glucose transporters found in the intestine and kidney (SGLT2); treating diabetes
09/26/2002US20020137694 Methods and compositions for the manufacture of C-3' and C-4' anthracycline antibiotics
09/26/2002US20020137690 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
09/25/2002EP1243652A2 Glial derived neurotrophic factor
09/25/2002EP1242438A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
09/25/2002EP1242435A2 Medicaments for treatment of respiratory syncytial virus infections
09/25/2002EP1242420A2 Agents and methods for the treatment of proliferative diseases
09/25/2002EP1242110A1 A method and composition for treating prostate cancer
09/25/2002EP1064293B1 Crystallization of lactitol, crystalline lactitol product and use thereof
09/25/2002EP0912613B1 Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same
09/25/2002EP0751948B1 Novel phosphoramidate and phophorothioamidate oligomeric compounds
09/25/2002CN1091447C 4,7-dialkoxy-N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses inclinical specimens
09/25/2002CN1091446C Colchicine derivatives, use thereof and formulations containing them
09/24/2002US6455572 Estrogen agonist/antagonist metabolites
09/19/2002WO2002072593A2 Alkylated c-sugars and uses thereof
09/19/2002WO2002072110A1 Caloporoside derivatives, methods for the production thereof and their use
09/19/2002US20020132310 Derivatized reduced malto-oligosaccharides
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 180